Part 3/7:
In the press release surrounding his investment, Icahn was enthusiastic in his praise for Saunders. This particular endorsement is noteworthy, given their history—Icahn previously achieved substantial gains with Saunders during his time at Forest Laboratories, a company that was eventually acquired and transitioned into Allergan. Many see this investment as Icahn’s attempt to replicate past successes, positioning himself to benefit alongside Saunders once again.